4/A//SEC Filing
Khosrovi Behzad 4/A
Accession 0001140361-10-045867
CIK 0001389545other
Filed
Nov 14, 7:00 PM ET
Accepted
Nov 15, 6:20 PM ET
Size
6.0 KB
Accession
0001140361-10-045867
Insider Transaction Report
Form 4/AAmended
Khosrovi Behzad
VP Research and Development
Transactions
- Award
Option (right to buy)
2009-01-28+21,300→ 294,200 totalExercise: $1.56From: 2010-01-28Exp: 2019-01-28→ Common Stock (21,300 underlying)
Footnotes (1)
- [F1]Original Form 4 filed on February 12, 2009. This amended form is being filed to correct the total securities following reported transaction under Table II, Item 9 which should be 294,200 not 94,200.
Documents
Issuer
NovaBay Pharmaceuticals, Inc.
CIK 0001389545
Entity typeother
Related Parties
1- filerCIK 0001410078
Filing Metadata
- Form type
- 4/A
- Filed
- Nov 14, 7:00 PM ET
- Accepted
- Nov 15, 6:20 PM ET
- Size
- 6.0 KB